Guoxin Securities Co., Ltd.\'s sponsorship summary report on Shenlian Biomedical (Shanghai) Co., Ltd.\'s initial public offering of shares and listing on the Science and Technology Innovation Board
Shenlian Biotech: 2021 Annual Equity Distribution Implementation Notice
2021 Annual Equity Distribution Implementation Notice
No Data